Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker-guided anakinra treatment and stop strategy in systemic juvenile idiopathic arthritis
2015-004393-16Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anakinra in systemic juvenile idiopathic arthritis (SJIA), sponsored by University Medical Center Utrecht. Primary endpoint: Clinically inactive disease without medication at 1 year. Started Jul 2016; status: active.
02
Drugs
anakinra
03
Conditions
systemic juvenile idiopathic arthritis (SJIA)
Beyond the preview
Go deeper on 2015-004393-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004393-16.